Disney (Walt) Co. (The) (DIS) Closes 0.93% Down on the Day for December 23

Equities Staff |

Dow Jones component Disney (Walt) Co. (The) (DIS) saw its stock move -0.93% to $105.74, representing a per-share move of $0.996, on volume of 9.99 million shares for Wednesday.

Disney (Walt) Co. (The) currently has a total float of 1.65 billion shares and moves 10.04 million a day, on average. The stock opened at $107.21 on December 23 and traded between a low of $104.30 and a high of $107.24. The stock now has a 50-day SMA of $112.66 and 200-day SMA of $108.99, and it has a high of $122.08 and low of $90.00 over the last year.

Walt Disney Co together with its subsidiaries is a diversified entertainment company with operations in five business segments: Media Networks, Parks and Resorts, Studio Entertainment, Consumer Products and Interactive.

Based out of Burbank, CA, Disney (Walt) Co. (The) has 185,000 employees and is helmed by CEO Robert A. Iger.

For a deeper dive into the fundamentals of Disney (Walt) Co. (The), check out equities.com’s E.V.A. report for DIS.

GET TO KNOW THE DOW

The Dow Jones Industrial Average is the oldest and most-often cited stock market index for the American equities market. While it’s arguably outdated and inefficient, it remains the most visible representation of the stock market to the outside world. Consisting of 30 companies selected by the editorial board of the Wall Street Journal, it’s meant to give an overview of stock performances by looking at a slice of those mega- and large-cap companies deemed to best represent the broad economy.

The history of the index dates all the way back to 1896 when it was first created by Charles Dow, the legendary founding editor of the Wall Street Journal and founder of Dow Jones & Company, and Edward Jones, a statistician. The price-weighted, scaled index has since become a standard part of most major daily news recaps and has seen dozens of different companies pass through its ranks, with only General Electric (GE) remaining on the index since its inception.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…